Tharimmune Stock Technical Analysis
| THAR Stock | 3.59 0.36 11.15% |
As of the 28th of January, Tharimmune has the Coefficient Of Variation of 1000.45, risk adjusted performance of 0.0824, and Semi Deviation of 4.79. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tharimmune, as well as the relationship between them. Please validate Tharimmune variance, as well as the relationship between the value at risk and skewness to decide if Tharimmune is priced more or less accurately, providing market reflects its prevalent price of 3.59 per share. Given that Tharimmune has jensen alpha of 0.5442, we advise you to double-check Tharimmune's current market performance to make sure the company can sustain itself at a future point.
Tharimmune Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Tharimmune, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to TharimmuneTharimmune | Build AI portfolio with Tharimmune Stock |
Tharimmune Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 5.0 | Strong Buy | 1 | Odds |
Most Tharimmune analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Tharimmune stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Tharimmune, talking to its executives and customers, or listening to Tharimmune conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tharimmune. If investors know Tharimmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tharimmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tharimmune is measured differently than its book value, which is the value of Tharimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Tharimmune's value that differs from its market value or its book value, called intrinsic value, which is Tharimmune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tharimmune's market value can be influenced by many factors that don't directly affect Tharimmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tharimmune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tharimmune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tharimmune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tharimmune 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tharimmune's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tharimmune.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Tharimmune on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Tharimmune or generate 0.0% return on investment in Tharimmune over 90 days. Tharimmune is related to or competes with BioLineRx, GeoVax Labs, Adlai Nortye, Lunai Bioworks, SeaStar Medical, Ainos, and Apollomics. Tharimmune is entity of United States. It is traded as Stock on NASDAQ exchange. More
Tharimmune Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tharimmune's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tharimmune upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.31 | |||
| Information Ratio | 0.087 | |||
| Maximum Drawdown | 35.56 | |||
| Value At Risk | (9.23) | |||
| Potential Upside | 9.12 |
Tharimmune Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tharimmune's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tharimmune's standard deviation. In reality, there are many statistical measures that can use Tharimmune historical prices to predict the future Tharimmune's volatility.| Risk Adjusted Performance | 0.0824 | |||
| Jensen Alpha | 0.5442 | |||
| Total Risk Alpha | 0.0262 | |||
| Sortino Ratio | 0.1004 | |||
| Treynor Ratio | 0.7146 |
Tharimmune January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0824 | |||
| Market Risk Adjusted Performance | 0.7246 | |||
| Mean Deviation | 4.75 | |||
| Semi Deviation | 4.79 | |||
| Downside Deviation | 5.31 | |||
| Coefficient Of Variation | 1000.45 | |||
| Standard Deviation | 6.13 | |||
| Variance | 37.55 | |||
| Information Ratio | 0.087 | |||
| Jensen Alpha | 0.5442 | |||
| Total Risk Alpha | 0.0262 | |||
| Sortino Ratio | 0.1004 | |||
| Treynor Ratio | 0.7146 | |||
| Maximum Drawdown | 35.56 | |||
| Value At Risk | (9.23) | |||
| Potential Upside | 9.12 | |||
| Downside Variance | 28.23 | |||
| Semi Variance | 22.91 | |||
| Expected Short fall | (5.50) | |||
| Skewness | 0.6981 | |||
| Kurtosis | 1.6 |
Tharimmune Backtested Returns
Tharimmune appears to be very risky, given 3 months investment horizon. Tharimmune owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0804, which indicates the firm had a 0.0804 % return per unit of risk over the last 3 months. By inspecting Tharimmune's technical indicators, you can evaluate if the expected return of 0.5% is justified by implied risk. Please review Tharimmune's Coefficient Of Variation of 1000.45, semi deviation of 4.79, and Risk Adjusted Performance of 0.0824 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Tharimmune holds a performance score of 6. The entity has a beta of 0.84, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tharimmune's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tharimmune is expected to be smaller as well. Please check Tharimmune's value at risk, and the relationship between the jensen alpha and skewness , to make a quick decision on whether Tharimmune's existing price patterns will revert.
Auto-correlation | -0.64 |
Very good reverse predictability
Tharimmune has very good reverse predictability. Overlapping area represents the amount of predictability between Tharimmune time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tharimmune price movement. The serial correlation of -0.64 indicates that roughly 64.0% of current Tharimmune price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.64 | |
| Spearman Rank Test | -0.36 | |
| Residual Average | 0.0 | |
| Price Variance | 0.11 |
Tharimmune technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Tharimmune Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Tharimmune volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Tharimmune Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Tharimmune on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Tharimmune based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Tharimmune price pattern first instead of the macroeconomic environment surrounding Tharimmune. By analyzing Tharimmune's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Tharimmune's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Tharimmune specific price patterns or momentum indicators. Please read more on our technical analysis page.
Tharimmune January 28, 2026 Technical Indicators
Most technical analysis of Tharimmune help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Tharimmune from various momentum indicators to cycle indicators. When you analyze Tharimmune charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0824 | |||
| Market Risk Adjusted Performance | 0.7246 | |||
| Mean Deviation | 4.75 | |||
| Semi Deviation | 4.79 | |||
| Downside Deviation | 5.31 | |||
| Coefficient Of Variation | 1000.45 | |||
| Standard Deviation | 6.13 | |||
| Variance | 37.55 | |||
| Information Ratio | 0.087 | |||
| Jensen Alpha | 0.5442 | |||
| Total Risk Alpha | 0.0262 | |||
| Sortino Ratio | 0.1004 | |||
| Treynor Ratio | 0.7146 | |||
| Maximum Drawdown | 35.56 | |||
| Value At Risk | (9.23) | |||
| Potential Upside | 9.12 | |||
| Downside Variance | 28.23 | |||
| Semi Variance | 22.91 | |||
| Expected Short fall | (5.50) | |||
| Skewness | 0.6981 | |||
| Kurtosis | 1.6 |
Tharimmune January 28, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Tharimmune stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 333,026 | ||
| Daily Balance Of Power | 0.67 | ||
| Rate Of Daily Change | 1.11 | ||
| Day Median Price | 3.47 | ||
| Day Typical Price | 3.51 | ||
| Price Action Indicator | 0.30 |
Additional Tools for Tharimmune Stock Analysis
When running Tharimmune's price analysis, check to measure Tharimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tharimmune is operating at the current time. Most of Tharimmune's value examination focuses on studying past and present price action to predict the probability of Tharimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tharimmune's price. Additionally, you may evaluate how the addition of Tharimmune to your portfolios can decrease your overall portfolio volatility.